title: High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi.
abstract: Mortality from bacterial meningitis in African adults is significantly higher than those in better resourced settings and adjunctive therapeutic interventions such as dexamethasone and glycerol have been shown to be ineffective. We conducted a study analysing data from clinical trials of bacterial meningitis in Blantyre, Malawi to investigate the clinical parameters associated with this high mortality.
  
  
  METHODS
  We searched for all clinical trials undertaken in Blantyre investigating bacterial meningitis from 1990 to the current time and combined the data from all included trial datasets into one database. We used logistic regression to relate individual clinical parameters to mortality. Adults with community acquired bacterial meningitis were included if the CSF culture isolate was consistent with meningitis or if the CSF white cell count was >100 cells/mm(3) (>50% neutrophils) in HIV negative participants and >5 cells/mm(3) in HIV positive participants. Outcome was measured by mortality at discharge from hospital (after 10 days of antibiotic therapy) and community follow up (day 40).
  
  
  RESULTS
  Seven hundred and fifteen episodes of bacterial meningitis were evaluated. The mortality rate was 45% at day 10 and 54% at day 40. The most common pathogens were S.pneumoniae (84% of positive CSF isolates) and N.meningitidis (4%). 607/694 (87%) participants tested were HIV antibody positive. Treatment delays within the hospital system were marked. The median presenting GCS was 12/15, 17% had GCS<8 and 44.9% had a seizure during the illness. Coma, seizures, tachycardia and anaemia were all significantly associated with mortality on multivariate analysis. HIV status and pneumococcal culture positivity in the CSF were not associated with mortality. Adults with community acquired bacterial meningitis in Malawi present with a severe clinical phenotype. Predictors of high mortality are different to those seen in Western settings. Optimising in-hospital care and minimising treatment delays presents an opportunity to improve outcomes considerably.
authors.affiliation: Clinical group, Liverpool School of Tropical Medicine, Liverpool, United Kingdom. emma.wall@doctors.org.uk
authors.forename: Emma C
authors.initials: EC
authors.lastname: Wall
authors.forename: Katharine
authors.initials: K
authors.lastname: Cartwright
authors.forename: Matthew
authors.initials: M
authors.lastname: Scarborough
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Ajdukiewicz
authors.forename: Patrick
authors.initials: P
authors.lastname: Goodson
authors.forename: James
authors.initials: J
authors.lastname: Mwambene
authors.forename: Eduard E
authors.initials: EE
authors.lastname: Zijlstra
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Gordon
authors.forename: Neil
authors.initials: N
authors.lastname: French
authors.forename: Brian
authors.initials: B
authors.lastname: Faragher
authors.forename: Robert S
authors.initials: RS
authors.lastname: Heyderman
authors.forename: David G
authors.initials: DG
authors.lastname: Lalloo
mesh_terms: D000328:Adult; D017954:Africa South of the Sahara / Q000453:epidemiology; D005260:Female; D006801:Humans; D008295:Malawi / Q000453:epidemiology; D008297:Male; D016920:Meningitis, Bacterial / Q000453:epidemiology* / Q000401:mortality; D008875:Middle Aged; D016017:Odds Ratio; D011379:Prognosis; D012307:Risk Factors; D055815:Young Adult
references.citation: Arch Intern Med. 2005 Jul 11;165(13):1533-40
references.pmid: 16009870
references.citation: Pediatr Infect Dis J. 2011 Dec;30(12):1075-80
references.pmid: 21799459
references.citation: PLoS One. 2011 Mar 15;6(3):e17765
references.pmid: 21423577
references.citation: Emerg Infect Dis. 2011 Jun;17(6):1107-9
references.pmid: 21749782
references.citation: PLoS Med. 2013;10(3):e1001400
references.pmid: 23554578
references.citation: Infection. 2000 Jan-Feb;28(1):3-7
references.pmid: 10697783
references.citation: Clin Infect Dis. 2013 Jan;56(2):291-9
references.pmid: 23024291
references.citation: J Accid Emerg Med. 1998 Sep;15(5):298-303
references.pmid: 9785154
references.citation: N Engl J Med. 2011 May 26;364(21):2016-25
references.pmid: 21612470
references.citation: Lancet Infect Dis. 2011 Apr;11(4):293-300
references.pmid: 21334262
references.citation: AIDS. 2000 Jul 7;14(10):1401-7
references.pmid: 10930155
references.citation: BMC Infect Dis. 2010 Mar 15;10:67
references.pmid: 20230635
references.citation: J Infect. 2008 Dec;57(6):449-54
references.pmid: 19000639
references.citation: N Engl J Med. 2007 Dec 13;357(24):2441-50
references.pmid: 18077809
references.citation: N Engl J Med. 2002 Nov 14;347(20):1549-56
references.pmid: 12432041
references.citation: N Engl J Med. 2010 Mar 4;362(9):812-22
references.pmid: 20200385
references.citation: Trop Med Int Health. 2010 Aug;15(8):910-7
references.pmid: 20573075
references.citation: J Neurovirol. 2005;11 Suppl 3:6-10
references.pmid: 16540447
references.citation: South Med J. 1983 Mar;76(3):322-7
references.pmid: 6828899
references.citation: J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):582-7
references.pmid: 19512939
references.citation: Crit Care Med. 2006 Nov;34(11):2758-65
references.pmid: 16915106
references.citation: QJM. 2007 Jan;100(1):37-40
references.pmid: 17178734
references.citation: N Engl J Med. 1993 Jan 7;328(1):21-8
references.pmid: 8416268
references.citation: Ann Intern Med. 2006 Jan 3;144(1):1-9
references.pmid: 16389249
references.citation: Arch Dis Child. 2001 Nov;85(5):386-90
references.pmid: 11668100
references.citation: Clin Infect Dis. 2000 Jul;31(1):53-7
references.pmid: 10913396
references.citation: Eur J Clin Microbiol Infect Dis. 2009 Nov;28(11):1317-25
references.pmid: 19727871
references.citation: N Engl J Med. 2004 Oct 28;351(18):1849-59
references.pmid: 15509818
references.citation: Trop Med Int Health. 2008 Jun;13(6):788-94
references.pmid: 18384480
references.citation: Lancet Infect Dis. 2010 May;10(5):317-28
references.pmid: 20417414
references.citation: BMC Infect Dis. 2009 May 08;9:57
references.pmid: 19426501
references.citation: QJM. 2006 Nov;99(11):761-9
references.pmid: 17071621
references.citation: AIDS. 2010 Jun 1;24(9):1351-60
references.pmid: 20559040
references.citation: N Engl J Med. 2004 Oct 28;351(18):1826-8
references.pmid: 15509815
references.citation: BMJ. 2006 Jun 3;332(7553):1295-8
references.pmid: 16554335
references.citation: Intensive Care Med. 2008 Jan;34(1):17-60
references.pmid: 18058085
references.citation: Trans R Soc Trop Med Hyg. 2005 Aug;99(8):561-7
references.pmid: 15893781
references.citation: Pediatr Infect Dis J. 2013 Feb;32(2):e54-61
references.pmid: 22914560
references.citation: J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):31-8
references.pmid: 22156821
references.citation: Med Trop (Mars). 2008 Dec;68(6):625-8
references.pmid: 19639833
references.citation: Cochrane Database Syst Rev. 2003;(3):CD004405
references.pmid: 12918010